Impact of CD39 expression on CD4+ T lymphocytes and 6q deletion on outcome of patients with chronic lymphocytic leukemia

Campo, 2011, The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications, Blood, 117, 5019, 10.1182/blood-2011-01-293050 Lapalombella, 2010, Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway, Blood, 115, 2619, 10.1182/blood-2009-09-242438 Curiel, 2007, Tregs and rethinking cancer immunotherapy, J Clin Invest, 117, 1167, 10.1172/JCI31202 Bastid, 2015, Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity, Cancer Immunol Res, 3, 254, 10.1158/2326-6066.CIR-14-0018 Ott, 2013, CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients, Clin Cancer Res, 19, 5300, 10.1158/1078-0432.CCR-13-0143 Perry, 2012, Increased CD39 expression on CD4(+) T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia, Ann Hematol, 91, 1271, 10.1007/s00277-012-1425-2 Pulte, 2011, CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia, Clin Lymphoma Myeloma Leuk, 11, 367, 10.1016/j.clml.2011.06.005 Kienle, 2010, Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia, Haematologica, 95, 102, 10.3324/haematol.2009.010298 Zhang, 1997, Frequent deletions of 6q23-24 in B-cell nonHodgkin's lymphomas detected by fluorescence in situ hybridization, Genes Chromosomes Cancer, 18, 310, 10.1002/(SICI)1098-2264(199704)18:4<310::AID-GCC10>3.0.CO;2-K Stilgenbauer, 2002, German CLL Study Group (GCLLSG). Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course, Leukemia, 16, 993, 10.1038/sj.leu.2402537 Merup, 1998, 6q deletions in acute lymphoblastic leukemia and nonHodgkin's lymphomas, Blood, 91, 3397, 10.1182/blood.V91.9.3397 Cuneo, 2004, Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis, Leukemia, 18, 476, 10.1038/sj.leu.2403242 Welson, 2012, Molecular detection of 6q deletion in Egyptian patients with B-cell chronic lymphoproliferative disorders, Egypt J Haematol, 37, 129